The phIII trial will include 360 patients. If results from this trial are positive they will get market approval...so chances are they will IPO following market approval.
I would much more prefer to hold stocks in this company than in Dendreon or other peers...will see.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.